Skip to main content
Premium Trial:

Request an Annual Quote

Celera Registration Statement Declared Effective; Split with ABI Expected on July 1

NEW YORK (GenomeWeb News) – Celera’s registration statement with the US Securities and Exchange Commission was declared effective yesterday by the regulatory body, clearing the way for Celera’s formal separation from sister company Applied Biosystems and parent firm Applera.
 
The split will take place at 12:01 a.m. EDT, on July 1, subject to certain conditions, including receipt of certain contents and listing of Celera’s stock on the Nasdaq, according to an Applera statement.
 
Celera had filed for the split in April. Under terms of the separation, shareholders of the Applera Group-Celera Group tracking stock will receive one share of new Celera Corporation shares for each share of the tracking stock they currently own. Upon completion of the deal, Celera will become an independent, publicly traded company.
 
Celera will trade on the Nasdaq under its current ticker symbol, CRA, and its current tracking stock will be delisted from the New York Stock Exchange.

The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.